Novartis leads list of 2012's 20 biggest spenders for R&D

03/12/2013 | Genetic Engineering & Biotechnology News

Novartis, Roche Holding and Merck topped this ranking of biopharmaceutical companies based on spending for research and development last year. Pfizer and Johnson and Johnson came in fourth and fifth, respectively. Also making the top 10 were Sanofi, GlaxoSmithKline, Eli Lilly and Co., AstraZeneca and Abbott Laboratories.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Director of Governmental Programs
Bluegrass Family Health
Lexington, KY